000			03339nam a22003855i 4500
001			82131
003			ES-MaUEC
005			20230207040357.0
007			cr nn 008mamaa
008			141031s2015 gw | s |||| 0|eng d
020			_a9783319074108
024	7		_a10.1007/978-3-319-07410-8 _2doi
050		4	_aR727.37 _b2015 EB
100	1		_aMancia, Giuseppe. _932248 _0comprobar BNE20022064899
245	1	0	_aWhite Coat Hypertension : _bAn Unresolved Diagnostic and Therapeutic Problem _cby Giuseppe Mancia, Guido Grassi, Gianfranco Parati, Alberto Zanchetti.
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (VIII, 147 páginas) _b81 ilustraciones, 11 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_a1 Historical Notes -- 2 Definition, Terminology and Prevalence -- 3 Diagnostic Approach to white coat effect and white coat hypertension -- 4 Neurogenic and Non-neurogenic Mechanisms -- 5 Predictive Factors -- 6 White coat hypertension and cardiovascular morbidity and mortality -- 7 White coat hypertension and Target Organ Damage -- 8 White Coat Hypertension, metabolic risk factors, and cardiovascular risk profile -- 9 To Treat or Not To Treat?.
520	3		_aThis book addresses all aspects of white coat hypertension â€{u0D28}e phenomenon of raised blood pressure in a medical setting yet not elsewhere â€{u09B2}om its history to its pathophysiology, diagnosis and treatment. White coat hypertension is a common condition, accounting for 30â€{u4C25} of the overall hypertensive population. While many studies have addressed this condition, controversy still exists over whether it causes an increased risk to sufferers and should be treated.Â{u026E} the volume neurogenic and non-neurogenic mechanisms are discussed and the significance of various predictive factors, evaluated. The association of white coat hypertension with dysmetabolic risk factors, new-onset diabetes and other conditions is carefully reviewed. Further chapters consider the occurrence of asymptomatic organ damage and cardiovascular outcomes in affected patients, and helpful guidance is also provided on the controversial issue of when to treat and when not to treat. White Coat Hypertension is based largely on work done during the past 30 years by renowned researchers working in Milan, who have made key contributions in improving knowledge of the condition and whose work is well known across the world.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aDiabetes. _9138582 _2embne
650		7	_aMédicos y pacientes _2embne _9147258
700	1		_aGrassi, Guido. _943248
700	1		_aParati, Gianfranco. _994847 _0Local
700	1		_aZanchetti, Alberto _0Local _994848
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-07410-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907			_a.b12907716 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aR727.37 M363 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11575396 _z06-04-17
999			_c82131 _d82131 _x1